What's breaking now, across thousands of outlets.
Fosun Pharma sold a 6% stake in Gland Pharma for ₹2,800 crore via a block deal, reducing its holding to 45.77%. Major buyers included Kotak, Axis, and ICICI Prudential Mutual Funds, while Gland Pharma shares closed higher at ₹2,932.40.
We haven't written up this one. The Economic Times - Top News has the full story — the link below goes straight to it.
“None of this is efficiency,” one food safety expert said of DOGE’s government personnel and research cuts. "This is all whatever the opposite of efficiency is.”
Employer health benefit costs are projected to see the steepest increase next year since 2003. That could mean higher deductions and out-of-pocket costs for workers.
Mumbai: Maharashtra has made significant progress in organ donation, with thousands of patients receiving transplants, Health Minister Prakash Abitkar said on Friday, calling for sustained awareness…
Older female mice—equivalent in age to 60-year-old women—given daily injections of the active ingredient in Ozempic lived about 12 percent longer than animals that didn't receive the drug
A new animal-based study has found GLP-1s could have the potential to do more than curb appetite—they may even extend life span.
(MedPage Today) -- It's been almost a month since Sen. Mitch McConnell (R-Ky.) last shared a health update, leading to another round of speculation about when -- or if -- he will return to Congress…
